version 8 0 statistical software packages Search Results


90
SPSS Inc version 8.0 computer software package
Version 8.0 Computer Software Package, supplied by SPSS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/version 8.0 computer software package/product/SPSS Inc
Average 90 stars, based on 1 article reviews
version 8.0 computer software package - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Qiagen clc genomics workbench version 8.0.1 rna-seq analysis software package
(a) Volcano plot showing <t>RNA-seq</t> data from Figure 2 with all genes (gray) or Myc pathway (Hallmark_MYC_TARGETS_V1) genes (red) in activated versus suppressed B cells. (b) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the Myc inhibitor 10058-F4 (F4). (c) IgG antibody concentration in culture supernatants from suppression assays in (b). (d) IgG1+GL7+ (left) or GL7 expression (right) in B cells from suppression assays in which control (WT) or Myc overexpressing (Myc) B cells were cultured with TFH alone or with TFR cells. (e) IgG concentration in culture supernatants from assays as in (c). (f) Volcano plot showing RNA-seq data from Figure 2 with all genes (gray) or mTOR signaling (Hallmark_MTORC1_SIGNALING) genes (red) in activated versus suppressed B cells. (g) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the mTOR inhibitor rapamycin (Rapa). (h) IgG concentration in culture supernatants from suppression assays in (b). (i) Quantification of IgG1+GL7+ B cells from suppression assays performed as in (b) with the addition of the mTOR inhibitor PP242. (j) IgG concentration in culture supernatants from suppression assays in (i). *p<0.05, **p<0.01, ***p<0.001 (using 1-way ANOVA with Tukey’s correction (b,c,d,e,h,i,j) or Chi2 test (a,f). Data are from one experiment (technical replicate suppression assays utilizing cells from 20 pooled mice) and are representative of 3 independent experiments with similar results (b–e, g–j mean±s.e.m.).
Clc Genomics Workbench Version 8.0.1 Rna Seq Analysis Software Package, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clc genomics workbench version 8.0.1 rna-seq analysis software package/product/Qiagen
Average 90 stars, based on 1 article reviews
clc genomics workbench version 8.0.1 rna-seq analysis software package - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
SPSS Inc software package windows version 8.0.1j
(a) Volcano plot showing <t>RNA-seq</t> data from Figure 2 with all genes (gray) or Myc pathway (Hallmark_MYC_TARGETS_V1) genes (red) in activated versus suppressed B cells. (b) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the Myc inhibitor 10058-F4 (F4). (c) IgG antibody concentration in culture supernatants from suppression assays in (b). (d) IgG1+GL7+ (left) or GL7 expression (right) in B cells from suppression assays in which control (WT) or Myc overexpressing (Myc) B cells were cultured with TFH alone or with TFR cells. (e) IgG concentration in culture supernatants from assays as in (c). (f) Volcano plot showing RNA-seq data from Figure 2 with all genes (gray) or mTOR signaling (Hallmark_MTORC1_SIGNALING) genes (red) in activated versus suppressed B cells. (g) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the mTOR inhibitor rapamycin (Rapa). (h) IgG concentration in culture supernatants from suppression assays in (b). (i) Quantification of IgG1+GL7+ B cells from suppression assays performed as in (b) with the addition of the mTOR inhibitor PP242. (j) IgG concentration in culture supernatants from suppression assays in (i). *p<0.05, **p<0.01, ***p<0.001 (using 1-way ANOVA with Tukey’s correction (b,c,d,e,h,i,j) or Chi2 test (a,f). Data are from one experiment (technical replicate suppression assays utilizing cells from 20 pooled mice) and are representative of 3 independent experiments with similar results (b–e, g–j mean±s.e.m.).
Software Package Windows Version 8.0.1j, supplied by SPSS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/software package windows version 8.0.1j/product/SPSS Inc
Average 90 stars, based on 1 article reviews
software package windows version 8.0.1j - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
SAS institute statistical software package proc mixed version 8.0
(a) Volcano plot showing <t>RNA-seq</t> data from Figure 2 with all genes (gray) or Myc pathway (Hallmark_MYC_TARGETS_V1) genes (red) in activated versus suppressed B cells. (b) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the Myc inhibitor 10058-F4 (F4). (c) IgG antibody concentration in culture supernatants from suppression assays in (b). (d) IgG1+GL7+ (left) or GL7 expression (right) in B cells from suppression assays in which control (WT) or Myc overexpressing (Myc) B cells were cultured with TFH alone or with TFR cells. (e) IgG concentration in culture supernatants from assays as in (c). (f) Volcano plot showing RNA-seq data from Figure 2 with all genes (gray) or mTOR signaling (Hallmark_MTORC1_SIGNALING) genes (red) in activated versus suppressed B cells. (g) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the mTOR inhibitor rapamycin (Rapa). (h) IgG concentration in culture supernatants from suppression assays in (b). (i) Quantification of IgG1+GL7+ B cells from suppression assays performed as in (b) with the addition of the mTOR inhibitor PP242. (j) IgG concentration in culture supernatants from suppression assays in (i). *p<0.05, **p<0.01, ***p<0.001 (using 1-way ANOVA with Tukey’s correction (b,c,d,e,h,i,j) or Chi2 test (a,f). Data are from one experiment (technical replicate suppression assays utilizing cells from 20 pooled mice) and are representative of 3 independent experiments with similar results (b–e, g–j mean±s.e.m.).
Statistical Software Package Proc Mixed Version 8.0, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/statistical software package proc mixed version 8.0/product/SAS institute
Average 90 stars, based on 1 article reviews
statistical software package proc mixed version 8.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Umetrics software package modde 2006 version 8.0
(a) Volcano plot showing <t>RNA-seq</t> data from Figure 2 with all genes (gray) or Myc pathway (Hallmark_MYC_TARGETS_V1) genes (red) in activated versus suppressed B cells. (b) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the Myc inhibitor 10058-F4 (F4). (c) IgG antibody concentration in culture supernatants from suppression assays in (b). (d) IgG1+GL7+ (left) or GL7 expression (right) in B cells from suppression assays in which control (WT) or Myc overexpressing (Myc) B cells were cultured with TFH alone or with TFR cells. (e) IgG concentration in culture supernatants from assays as in (c). (f) Volcano plot showing RNA-seq data from Figure 2 with all genes (gray) or mTOR signaling (Hallmark_MTORC1_SIGNALING) genes (red) in activated versus suppressed B cells. (g) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the mTOR inhibitor rapamycin (Rapa). (h) IgG concentration in culture supernatants from suppression assays in (b). (i) Quantification of IgG1+GL7+ B cells from suppression assays performed as in (b) with the addition of the mTOR inhibitor PP242. (j) IgG concentration in culture supernatants from suppression assays in (i). *p<0.05, **p<0.01, ***p<0.001 (using 1-way ANOVA with Tukey’s correction (b,c,d,e,h,i,j) or Chi2 test (a,f). Data are from one experiment (technical replicate suppression assays utilizing cells from 20 pooled mice) and are representative of 3 independent experiments with similar results (b–e, g–j mean±s.e.m.).
Software Package Modde 2006 Version 8.0, supplied by Umetrics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/software package modde 2006 version 8.0/product/Umetrics
Average 90 stars, based on 1 article reviews
software package modde 2006 version 8.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Minitab Inc statistical software, version 8.0
(a) Volcano plot showing <t>RNA-seq</t> data from Figure 2 with all genes (gray) or Myc pathway (Hallmark_MYC_TARGETS_V1) genes (red) in activated versus suppressed B cells. (b) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the Myc inhibitor 10058-F4 (F4). (c) IgG antibody concentration in culture supernatants from suppression assays in (b). (d) IgG1+GL7+ (left) or GL7 expression (right) in B cells from suppression assays in which control (WT) or Myc overexpressing (Myc) B cells were cultured with TFH alone or with TFR cells. (e) IgG concentration in culture supernatants from assays as in (c). (f) Volcano plot showing RNA-seq data from Figure 2 with all genes (gray) or mTOR signaling (Hallmark_MTORC1_SIGNALING) genes (red) in activated versus suppressed B cells. (g) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the mTOR inhibitor rapamycin (Rapa). (h) IgG concentration in culture supernatants from suppression assays in (b). (i) Quantification of IgG1+GL7+ B cells from suppression assays performed as in (b) with the addition of the mTOR inhibitor PP242. (j) IgG concentration in culture supernatants from suppression assays in (i). *p<0.05, **p<0.01, ***p<0.001 (using 1-way ANOVA with Tukey’s correction (b,c,d,e,h,i,j) or Chi2 test (a,f). Data are from one experiment (technical replicate suppression assays utilizing cells from 20 pooled mice) and are representative of 3 independent experiments with similar results (b–e, g–j mean±s.e.m.).
Statistical Software, Version 8.0, supplied by Minitab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/statistical software, version 8.0/product/Minitab Inc
Average 90 stars, based on 1 article reviews
statistical software, version 8.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd software for windows, version 8.0
(a) Volcano plot showing <t>RNA-seq</t> data from Figure 2 with all genes (gray) or Myc pathway (Hallmark_MYC_TARGETS_V1) genes (red) in activated versus suppressed B cells. (b) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the Myc inhibitor 10058-F4 (F4). (c) IgG antibody concentration in culture supernatants from suppression assays in (b). (d) IgG1+GL7+ (left) or GL7 expression (right) in B cells from suppression assays in which control (WT) or Myc overexpressing (Myc) B cells were cultured with TFH alone or with TFR cells. (e) IgG concentration in culture supernatants from assays as in (c). (f) Volcano plot showing RNA-seq data from Figure 2 with all genes (gray) or mTOR signaling (Hallmark_MTORC1_SIGNALING) genes (red) in activated versus suppressed B cells. (g) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the mTOR inhibitor rapamycin (Rapa). (h) IgG concentration in culture supernatants from suppression assays in (b). (i) Quantification of IgG1+GL7+ B cells from suppression assays performed as in (b) with the addition of the mTOR inhibitor PP242. (j) IgG concentration in culture supernatants from suppression assays in (i). *p<0.05, **p<0.01, ***p<0.001 (using 1-way ANOVA with Tukey’s correction (b,c,d,e,h,i,j) or Chi2 test (a,f). Data are from one experiment (technical replicate suppression assays utilizing cells from 20 pooled mice) and are representative of 3 independent experiments with similar results (b–e, g–j mean±s.e.m.).
Software For Windows, Version 8.0, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/software for windows, version 8.0/product/MedCalc Software Ltd
Average 90 stars, based on 1 article reviews
software for windows, version 8.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Wolfram Research ndsolve function within the mathematica software package version 8.0
(a) Volcano plot showing <t>RNA-seq</t> data from Figure 2 with all genes (gray) or Myc pathway (Hallmark_MYC_TARGETS_V1) genes (red) in activated versus suppressed B cells. (b) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the Myc inhibitor 10058-F4 (F4). (c) IgG antibody concentration in culture supernatants from suppression assays in (b). (d) IgG1+GL7+ (left) or GL7 expression (right) in B cells from suppression assays in which control (WT) or Myc overexpressing (Myc) B cells were cultured with TFH alone or with TFR cells. (e) IgG concentration in culture supernatants from assays as in (c). (f) Volcano plot showing RNA-seq data from Figure 2 with all genes (gray) or mTOR signaling (Hallmark_MTORC1_SIGNALING) genes (red) in activated versus suppressed B cells. (g) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the mTOR inhibitor rapamycin (Rapa). (h) IgG concentration in culture supernatants from suppression assays in (b). (i) Quantification of IgG1+GL7+ B cells from suppression assays performed as in (b) with the addition of the mTOR inhibitor PP242. (j) IgG concentration in culture supernatants from suppression assays in (i). *p<0.05, **p<0.01, ***p<0.001 (using 1-way ANOVA with Tukey’s correction (b,c,d,e,h,i,j) or Chi2 test (a,f). Data are from one experiment (technical replicate suppression assays utilizing cells from 20 pooled mice) and are representative of 3 independent experiments with similar results (b–e, g–j mean±s.e.m.).
Ndsolve Function Within The Mathematica Software Package Version 8.0, supplied by Wolfram Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ndsolve function within the mathematica software package version 8.0/product/Wolfram Research
Average 90 stars, based on 1 article reviews
ndsolve function within the mathematica software package version 8.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Biotechnology Information genetics computer software package version 8.0
(a) Volcano plot showing <t>RNA-seq</t> data from Figure 2 with all genes (gray) or Myc pathway (Hallmark_MYC_TARGETS_V1) genes (red) in activated versus suppressed B cells. (b) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the Myc inhibitor 10058-F4 (F4). (c) IgG antibody concentration in culture supernatants from suppression assays in (b). (d) IgG1+GL7+ (left) or GL7 expression (right) in B cells from suppression assays in which control (WT) or Myc overexpressing (Myc) B cells were cultured with TFH alone or with TFR cells. (e) IgG concentration in culture supernatants from assays as in (c). (f) Volcano plot showing RNA-seq data from Figure 2 with all genes (gray) or mTOR signaling (Hallmark_MTORC1_SIGNALING) genes (red) in activated versus suppressed B cells. (g) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the mTOR inhibitor rapamycin (Rapa). (h) IgG concentration in culture supernatants from suppression assays in (b). (i) Quantification of IgG1+GL7+ B cells from suppression assays performed as in (b) with the addition of the mTOR inhibitor PP242. (j) IgG concentration in culture supernatants from suppression assays in (i). *p<0.05, **p<0.01, ***p<0.001 (using 1-way ANOVA with Tukey’s correction (b,c,d,e,h,i,j) or Chi2 test (a,f). Data are from one experiment (technical replicate suppression assays utilizing cells from 20 pooled mice) and are representative of 3 independent experiments with similar results (b–e, g–j mean±s.e.m.).
Genetics Computer Software Package Version 8.0, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/genetics computer software package version 8.0/product/Biotechnology Information
Average 90 stars, based on 1 article reviews
genetics computer software package version 8.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc statistics version 8.0
(a) Volcano plot showing <t>RNA-seq</t> data from Figure 2 with all genes (gray) or Myc pathway (Hallmark_MYC_TARGETS_V1) genes (red) in activated versus suppressed B cells. (b) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the Myc inhibitor 10058-F4 (F4). (c) IgG antibody concentration in culture supernatants from suppression assays in (b). (d) IgG1+GL7+ (left) or GL7 expression (right) in B cells from suppression assays in which control (WT) or Myc overexpressing (Myc) B cells were cultured with TFH alone or with TFR cells. (e) IgG concentration in culture supernatants from assays as in (c). (f) Volcano plot showing RNA-seq data from Figure 2 with all genes (gray) or mTOR signaling (Hallmark_MTORC1_SIGNALING) genes (red) in activated versus suppressed B cells. (g) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the mTOR inhibitor rapamycin (Rapa). (h) IgG concentration in culture supernatants from suppression assays in (b). (i) Quantification of IgG1+GL7+ B cells from suppression assays performed as in (b) with the addition of the mTOR inhibitor PP242. (j) IgG concentration in culture supernatants from suppression assays in (i). *p<0.05, **p<0.01, ***p<0.001 (using 1-way ANOVA with Tukey’s correction (b,c,d,e,h,i,j) or Chi2 test (a,f). Data are from one experiment (technical replicate suppression assays utilizing cells from 20 pooled mice) and are representative of 3 independent experiments with similar results (b–e, g–j mean±s.e.m.).
Statistics Version 8.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/statistics version 8.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
statistics version 8.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Seisan Nipponsha Ltd seismological software package seisan version 8.0
(a) Volcano plot showing <t>RNA-seq</t> data from Figure 2 with all genes (gray) or Myc pathway (Hallmark_MYC_TARGETS_V1) genes (red) in activated versus suppressed B cells. (b) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the Myc inhibitor 10058-F4 (F4). (c) IgG antibody concentration in culture supernatants from suppression assays in (b). (d) IgG1+GL7+ (left) or GL7 expression (right) in B cells from suppression assays in which control (WT) or Myc overexpressing (Myc) B cells were cultured with TFH alone or with TFR cells. (e) IgG concentration in culture supernatants from assays as in (c). (f) Volcano plot showing RNA-seq data from Figure 2 with all genes (gray) or mTOR signaling (Hallmark_MTORC1_SIGNALING) genes (red) in activated versus suppressed B cells. (g) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the mTOR inhibitor rapamycin (Rapa). (h) IgG concentration in culture supernatants from suppression assays in (b). (i) Quantification of IgG1+GL7+ B cells from suppression assays performed as in (b) with the addition of the mTOR inhibitor PP242. (j) IgG concentration in culture supernatants from suppression assays in (i). *p<0.05, **p<0.01, ***p<0.001 (using 1-way ANOVA with Tukey’s correction (b,c,d,e,h,i,j) or Chi2 test (a,f). Data are from one experiment (technical replicate suppression assays utilizing cells from 20 pooled mice) and are representative of 3 independent experiments with similar results (b–e, g–j mean±s.e.m.).
Seismological Software Package Seisan Version 8.0, supplied by Seisan Nipponsha Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/seismological software package seisan version 8.0/product/Seisan Nipponsha Ltd
Average 90 stars, based on 1 article reviews
seismological software package seisan version 8.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
SYSTAT graphics software package sigmaplot version 8.0
(a) Volcano plot showing <t>RNA-seq</t> data from Figure 2 with all genes (gray) or Myc pathway (Hallmark_MYC_TARGETS_V1) genes (red) in activated versus suppressed B cells. (b) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the Myc inhibitor 10058-F4 (F4). (c) IgG antibody concentration in culture supernatants from suppression assays in (b). (d) IgG1+GL7+ (left) or GL7 expression (right) in B cells from suppression assays in which control (WT) or Myc overexpressing (Myc) B cells were cultured with TFH alone or with TFR cells. (e) IgG concentration in culture supernatants from assays as in (c). (f) Volcano plot showing RNA-seq data from Figure 2 with all genes (gray) or mTOR signaling (Hallmark_MTORC1_SIGNALING) genes (red) in activated versus suppressed B cells. (g) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the mTOR inhibitor rapamycin (Rapa). (h) IgG concentration in culture supernatants from suppression assays in (b). (i) Quantification of IgG1+GL7+ B cells from suppression assays performed as in (b) with the addition of the mTOR inhibitor PP242. (j) IgG concentration in culture supernatants from suppression assays in (i). *p<0.05, **p<0.01, ***p<0.001 (using 1-way ANOVA with Tukey’s correction (b,c,d,e,h,i,j) or Chi2 test (a,f). Data are from one experiment (technical replicate suppression assays utilizing cells from 20 pooled mice) and are representative of 3 independent experiments with similar results (b–e, g–j mean±s.e.m.).
Graphics Software Package Sigmaplot Version 8.0, supplied by SYSTAT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/graphics software package sigmaplot version 8.0/product/SYSTAT
Average 90 stars, based on 1 article reviews
graphics software package sigmaplot version 8.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


(a) Volcano plot showing RNA-seq data from Figure 2 with all genes (gray) or Myc pathway (Hallmark_MYC_TARGETS_V1) genes (red) in activated versus suppressed B cells. (b) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the Myc inhibitor 10058-F4 (F4). (c) IgG antibody concentration in culture supernatants from suppression assays in (b). (d) IgG1+GL7+ (left) or GL7 expression (right) in B cells from suppression assays in which control (WT) or Myc overexpressing (Myc) B cells were cultured with TFH alone or with TFR cells. (e) IgG concentration in culture supernatants from assays as in (c). (f) Volcano plot showing RNA-seq data from Figure 2 with all genes (gray) or mTOR signaling (Hallmark_MTORC1_SIGNALING) genes (red) in activated versus suppressed B cells. (g) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the mTOR inhibitor rapamycin (Rapa). (h) IgG concentration in culture supernatants from suppression assays in (b). (i) Quantification of IgG1+GL7+ B cells from suppression assays performed as in (b) with the addition of the mTOR inhibitor PP242. (j) IgG concentration in culture supernatants from suppression assays in (i). *p<0.05, **p<0.01, ***p<0.001 (using 1-way ANOVA with Tukey’s correction (b,c,d,e,h,i,j) or Chi2 test (a,f). Data are from one experiment (technical replicate suppression assays utilizing cells from 20 pooled mice) and are representative of 3 independent experiments with similar results (b–e, g–j mean±s.e.m.).

Journal: Nature immunology

Article Title: Suppression by T FR cells leads to durable and selective inhibition of B cell effector functions

doi: 10.1038/ni.3578

Figure Lengend Snippet: (a) Volcano plot showing RNA-seq data from Figure 2 with all genes (gray) or Myc pathway (Hallmark_MYC_TARGETS_V1) genes (red) in activated versus suppressed B cells. (b) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the Myc inhibitor 10058-F4 (F4). (c) IgG antibody concentration in culture supernatants from suppression assays in (b). (d) IgG1+GL7+ (left) or GL7 expression (right) in B cells from suppression assays in which control (WT) or Myc overexpressing (Myc) B cells were cultured with TFH alone or with TFR cells. (e) IgG concentration in culture supernatants from assays as in (c). (f) Volcano plot showing RNA-seq data from Figure 2 with all genes (gray) or mTOR signaling (Hallmark_MTORC1_SIGNALING) genes (red) in activated versus suppressed B cells. (g) Quantification of IgG1+GL7+ B cells from suppression assays performed as in Figure 1 with the addition of the mTOR inhibitor rapamycin (Rapa). (h) IgG concentration in culture supernatants from suppression assays in (b). (i) Quantification of IgG1+GL7+ B cells from suppression assays performed as in (b) with the addition of the mTOR inhibitor PP242. (j) IgG concentration in culture supernatants from suppression assays in (i). *p<0.05, **p<0.01, ***p<0.001 (using 1-way ANOVA with Tukey’s correction (b,c,d,e,h,i,j) or Chi2 test (a,f). Data are from one experiment (technical replicate suppression assays utilizing cells from 20 pooled mice) and are representative of 3 independent experiments with similar results (b–e, g–j mean±s.e.m.).

Article Snippet: Analysis was performed using the CLC Genomics Workbench version 8.0.1 RNA-seq analysis software package (Qiagen).

Techniques: RNA Sequencing Assay, Concentration Assay, Expressing, Cell Culture

(a) Heat map of metabolic pathways using RNA-seq data from Fig. 2 (normalized to naive B cells) (Supplementary Figure 4). (b) Glut1 expression in B cells from activated (B + TFH), TFR-suppressed (B + TFH +TFR), or Treg-suppressed (B + TFH + Treg) cultures. (c) Glut1 expression in B cells, gated to indicate CTV division peaks. (d) Glut1 expression in B cells added to activated or suppressed day 3 cultures and harvested 20 hours later. (e) Glut1 expression in TFH cells. (f) Glucose uptake in culture supernatants as in (b). (g) Lactate production in culture supernatants from cultures as in (b). (h–i) IgG1+GL7+ B cells (left) and IgG concentration (right) in supernatants from cultures as in (b) to which 2DG was added. (j) Volcano plot of activated versus suppressed B cells showing all genes (gray) or genes encoding enzymes in one-carbon/serine/purine metabolism (red) using RNA-seq data from Fig. 2. (k) Shmt1 and Shmt2 expression in B cells added to activated or suppressed day 3 cultures and harvested 20 hours later. (l) IgG concentration in supernatants as in (c) with the addition of MTX. (m) IgG concentration in supernatants as in (c) with the addition of AZA. *p<0.05, **p<0.01, ***p<0.001 (Student’s t-test (d), 1-way ANOVA with Tukey’s correction (b, e–i, l–m), or Chi2 test (j). Data are from one experiment (technical replicate suppression assays utilizing cells from 20 pooled mice) and are representative of 3 independent experiments with similar results (b–i, k–m mean±s.e.m.).

Journal: Nature immunology

Article Title: Suppression by T FR cells leads to durable and selective inhibition of B cell effector functions

doi: 10.1038/ni.3578

Figure Lengend Snippet: (a) Heat map of metabolic pathways using RNA-seq data from Fig. 2 (normalized to naive B cells) (Supplementary Figure 4). (b) Glut1 expression in B cells from activated (B + TFH), TFR-suppressed (B + TFH +TFR), or Treg-suppressed (B + TFH + Treg) cultures. (c) Glut1 expression in B cells, gated to indicate CTV division peaks. (d) Glut1 expression in B cells added to activated or suppressed day 3 cultures and harvested 20 hours later. (e) Glut1 expression in TFH cells. (f) Glucose uptake in culture supernatants as in (b). (g) Lactate production in culture supernatants from cultures as in (b). (h–i) IgG1+GL7+ B cells (left) and IgG concentration (right) in supernatants from cultures as in (b) to which 2DG was added. (j) Volcano plot of activated versus suppressed B cells showing all genes (gray) or genes encoding enzymes in one-carbon/serine/purine metabolism (red) using RNA-seq data from Fig. 2. (k) Shmt1 and Shmt2 expression in B cells added to activated or suppressed day 3 cultures and harvested 20 hours later. (l) IgG concentration in supernatants as in (c) with the addition of MTX. (m) IgG concentration in supernatants as in (c) with the addition of AZA. *p<0.05, **p<0.01, ***p<0.001 (Student’s t-test (d), 1-way ANOVA with Tukey’s correction (b, e–i, l–m), or Chi2 test (j). Data are from one experiment (technical replicate suppression assays utilizing cells from 20 pooled mice) and are representative of 3 independent experiments with similar results (b–i, k–m mean±s.e.m.).

Article Snippet: Analysis was performed using the CLC Genomics Workbench version 8.0.1 RNA-seq analysis software package (Qiagen).

Techniques: RNA Sequencing Assay, Expressing, Concentration Assay

(a) Bcl6 and Ki67 expression in TFH cells from reactivation cultures. B and TFH cells were cultured alone or along with TFR cells. After 3 days, B cells from the activated culture (Act B) or suppressed culture (Supp B) were sorted and cultured with new T cells (2°). Primary activation cultures are also included (1°) (b) Relative percentage of total number of TFH cells in cultures as in (a). (c) IgG1+GL7+ B cells from cultures as in (a). (d) Glut1 expression in B cells from cultures as in (a). (e) Glucose uptake in supernatants from cultures as in (a). (f) Venn diagram showing genes with lower expression in B cells upon suppression from RNA-seq data (as in Fig. 2) and gene loci showing evidence of chromatin inaccessibility by ATAC-seq. (g) RNA-seq data for gene transcripts expressed less in suppressed B cells by RNA-seq and which also showed less accessibility by ATAC-seq analysis. (h–j) ATAC-seq peaks and ChIA-pet annotated B cell regulome gene track33 for Aicda, Myc and Pou2af1. Red boxes indicate statistical downregulation (P<0.05). (k) Distance of ATAC-seq peaks from gene transcriptional start sites (TSS) for all peaks or peaks less accessible in suppressed B cells. *p<0.05, **p<0.01, ***p<0.001 (1-way ANOVA with Tukey’s correction (a–e). Data are pooled data from 10 independent experiments, each of which included cells from 20 pooled mice (a–e mean±s.e.m.), or are representative of two independent experiments (f–k).

Journal: Nature immunology

Article Title: Suppression by T FR cells leads to durable and selective inhibition of B cell effector functions

doi: 10.1038/ni.3578

Figure Lengend Snippet: (a) Bcl6 and Ki67 expression in TFH cells from reactivation cultures. B and TFH cells were cultured alone or along with TFR cells. After 3 days, B cells from the activated culture (Act B) or suppressed culture (Supp B) were sorted and cultured with new T cells (2°). Primary activation cultures are also included (1°) (b) Relative percentage of total number of TFH cells in cultures as in (a). (c) IgG1+GL7+ B cells from cultures as in (a). (d) Glut1 expression in B cells from cultures as in (a). (e) Glucose uptake in supernatants from cultures as in (a). (f) Venn diagram showing genes with lower expression in B cells upon suppression from RNA-seq data (as in Fig. 2) and gene loci showing evidence of chromatin inaccessibility by ATAC-seq. (g) RNA-seq data for gene transcripts expressed less in suppressed B cells by RNA-seq and which also showed less accessibility by ATAC-seq analysis. (h–j) ATAC-seq peaks and ChIA-pet annotated B cell regulome gene track33 for Aicda, Myc and Pou2af1. Red boxes indicate statistical downregulation (P<0.05). (k) Distance of ATAC-seq peaks from gene transcriptional start sites (TSS) for all peaks or peaks less accessible in suppressed B cells. *p<0.05, **p<0.01, ***p<0.001 (1-way ANOVA with Tukey’s correction (a–e). Data are pooled data from 10 independent experiments, each of which included cells from 20 pooled mice (a–e mean±s.e.m.), or are representative of two independent experiments (f–k).

Article Snippet: Analysis was performed using the CLC Genomics Workbench version 8.0.1 RNA-seq analysis software package (Qiagen).

Techniques: Expressing, Cell Culture, Activation Assay, RNA Sequencing Assay, ChIA Pet Assay

(a) (Left) B cell proliferation in B cells from cultures of TFH cells alone, TFH and TFR cells, or TFH and TFR cells with IL-21. (Right) Quantification of proliferation index. (b) IgG1+GL7+ B cells from cultures as in (a). (c) IgG concentration in culture supernatants from cultures as in (a). IL-4 (left) or IL-6 (right) was added. (d) Glut1 expression in B cells from cultures as in (a). (e) Glucose uptake from culture supernatants as in (a). (f) Lactate production in culture supernatants as in (a). (g) IgG concentration in culture supernatants as in (a), to which 2DG was added. (h) Volcano plot showing all genes (gray) or B cell function genes (red) from sorted B cells in Suppressed + IL-21 versus Suppressed cultures. Cultures were performed as in (a) except NP-OVA was used instead of anti-CD3/IgM. (i) Venn diagram of all genes differentially expressed (FDR adjusted p<0.05) for RNA-seq analysis as in (h). (j) Collapsed ssGSEA correlation plots for Activated, Suppressed or Suppressed + IL-21 B cell RNA-seq data. *p<0.05, **p<0.01, ***p<0.001 using 1 way ANOVA with Tukey’s correction (a–g). Data are from one experiment (technical replicate suppression assays utilizing cells from 20 pooled mice) are representative of 3 independent experiments with similar results (a–g, mean±s.e.m.), or are combined 3 biological replicates (h–j).

Journal: Nature immunology

Article Title: Suppression by T FR cells leads to durable and selective inhibition of B cell effector functions

doi: 10.1038/ni.3578

Figure Lengend Snippet: (a) (Left) B cell proliferation in B cells from cultures of TFH cells alone, TFH and TFR cells, or TFH and TFR cells with IL-21. (Right) Quantification of proliferation index. (b) IgG1+GL7+ B cells from cultures as in (a). (c) IgG concentration in culture supernatants from cultures as in (a). IL-4 (left) or IL-6 (right) was added. (d) Glut1 expression in B cells from cultures as in (a). (e) Glucose uptake from culture supernatants as in (a). (f) Lactate production in culture supernatants as in (a). (g) IgG concentration in culture supernatants as in (a), to which 2DG was added. (h) Volcano plot showing all genes (gray) or B cell function genes (red) from sorted B cells in Suppressed + IL-21 versus Suppressed cultures. Cultures were performed as in (a) except NP-OVA was used instead of anti-CD3/IgM. (i) Venn diagram of all genes differentially expressed (FDR adjusted p<0.05) for RNA-seq analysis as in (h). (j) Collapsed ssGSEA correlation plots for Activated, Suppressed or Suppressed + IL-21 B cell RNA-seq data. *p<0.05, **p<0.01, ***p<0.001 using 1 way ANOVA with Tukey’s correction (a–g). Data are from one experiment (technical replicate suppression assays utilizing cells from 20 pooled mice) are representative of 3 independent experiments with similar results (a–g, mean±s.e.m.), or are combined 3 biological replicates (h–j).

Article Snippet: Analysis was performed using the CLC Genomics Workbench version 8.0.1 RNA-seq analysis software package (Qiagen).

Techniques: Concentration Assay, Expressing, Cell Function Assay, RNA Sequencing Assay